Ameritas Investment Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.4M | Buy |
21,664
+112
| +0.5% | +$7.89K | 0.04% | 483 |
|
|
2025
Q4 | $1.45M | Sell |
21,552
-374
| -2% | -$25.2K | 0.04% | 462 |
|
|
2025
Q3 | $1.61M | Sell |
21,926
-1,999
| -8% | -$133K | 0.05% | 416 |
|
|
2025
Q2 | $1.24M | Sell |
23,925
-13,869
| -37% | -$789K | 0.04% | 539 |
|
|
2025
Q1 | $2.41M | Sell |
37,794
-450
| -1% | -$26.1K | 0.08% | 249 |
|
|
2024
Q4 | $1.83M | Sell |
38,244
-382
| -1% | -$19.6K | 0.06% | 367 |
|
|
2024
Q3 | $2.21M | Sell |
38,626
-667
| -2% | -$38.2K | 0.07% | 300 |
|
|
2024
Q2 | $2.06M | Sell |
39,293
-2,989
| -7% | -$131K | 0.07% | 288 |
|
|
2024
Q1 | $1.72M | Hold |
42,282
| – | – | 0.06% | 396 |
|
|
2023
Q4 | $1.56M | Sell |
42,282
-75
| -0.2% | -$2.83K | 0.06% | 415 |
|
|
2023
Q3 | $1.62M | Sell |
42,357
-1,555
| -4% | -$63.7K | 0.06% | 338 |
|
|
2023
Q2 | $1.58M | Sell |
43,912
-1,207
| -3% | -$41.2K | 0.06% | 390 |
|
|
2023
Q1 | $1.72M | Sell |
45,119
-312
| -0.7% | -$14.6K | 0.07% | 344 |
|
|
2022
Q4 | $2.34M | Sell |
45,431
-642
| -1% | -$32.9K | 0.09% | 231 |
|
|
2022
Q3 | $1.82M | Sell |
46,073
-894
| -2% | -$39.5K | 0.08% | 270 |
|
|
2022
Q2 | $2.07M | Sell |
46,967
-1,437
| -3% | -$62.1K | 0.09% | 229 |
|
|
2022
Q1 | $1.93M | Hold |
48,404
| – | – | 0.07% | 330 |
|
|
2021
Q4 | $1.95M | Sell |
48,404
-318
| -0.7% | -$11.9K | 0.07% | 346 |
|
|
2021
Q3 | $1.98M | Buy |
48,722
+1,496
| +3% | +$62.5K | 0.07% | 311 |
|
|
2021
Q2 | $2.15M | Buy |
47,226
+1,290
| +3% | +$57.1K | 0.08% | 295 |
|
|
2021
Q1 | $1.92M | Sell |
45,936
-323
| -0.7% | -$14.7K | 0.07% | 317 |
|
|
2020
Q4 | $1.98M | Buy |
46,259
+34,686
| +300% | +$1.25M | 0.09% | 270 |
|
|
2020
Q3 | $304K | Sell |
11,573
-425
| -4% | -$11.8K | 0.01% | 864 |
|
|
2020
Q2 | $322K | Buy |
11,998
+342
| +3% | +$7.71K | 0.02% | 835 |
|
|
2020
Q1 | $210K | Sell |
11,656
-545
| -4% | -$10.3K | 0.01% | 913 |
|
|
2019
Q4 | $216K | Hold |
12,201
| – | – | 0.01% | 1046 |
|
|
2019
Q3 | $189K | Hold |
12,201
| – | – | 0.01% | 1080 |
|
|
2019
Q2 | $210K | Buy |
12,201
+1,516
| +14% | +$24.5K | 0.01% | 1032 |
|
|
2019
Q1 | $172K | Hold |
10,685
| – | – | 0.01% | 1125 |
|
|
2018
Q4 | $156K | Hold |
10,685
| – | – | 0.01% | 1100 |
|
|
2018
Q3 | $194K | Hold |
10,685
| – | – | 0.01% | 1100 |
|
|
2018
Q2 | $180K | Buy |
10,685
+517
| +5% | +$9.78K | 0.01% | 1124 |
|
|
2018
Q1 | $199K | Hold |
10,168
| – | – | 0.01% | 1069 |
|
|
2017
Q4 | $206K | Buy |
10,168
+752
| +8% | +$13.8K | 0.01% | 1070 |
|
|
2017
Q3 | $122K | Hold |
9,416
| – | – | 0.01% | 1340 |
|
|
2017
Q2 | $121K | Hold |
9,416
| – | – | 0.01% | 1349 |
|
|
2017
Q1 | $122K | Buy |
+9,416
| New | +$119K | 0.01% | 1317 |
|
Other funds holding HALO
VCM
VPM
Ameritas Investment Partners's HALO Position: Q1 2026 in Review
Ameritas Investment Partners increased its Halozyme (HALO) stake by 0.52% in Q1 2026, buying an estimated $7.89K and bringing the position to 21,664 shares worth $1.4M. The position accounts for 0.04% of the portfolio, ranked #483.
Ameritas Investment Partners first reported a position in HALO in Q1 2017 and has held it in 37 quarters since. The position peaked at $2.41M in Q1 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Ameritas Investment Partners held 21,664 shares of Halozyme worth $1.4M as of Q1 2026.
- Ameritas Investment Partners bought 112 Halozyme shares in Q1 2026, an estimated $7.89K.
- Halozyme made up 0.04% of Ameritas Investment Partners's portfolio in Q1 2026, its #483 holding.
- Ameritas Investment Partners first reported a position in Halozyme in Q1 2017 and has held it in 37 quarters since.
- Ameritas Investment Partners's Halozyme position peaked at $2.41M in Q1 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.